Sergio
Vaño Galván
Profesor/a Asociado/a en CC. de la Salud


Hamad Medical Corporation
Doha, QatarPublications in collaboration with researchers from Hamad Medical Corporation (1)
2024
-
Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
Dermatology and Therapy, Vol. 14, Núm. 10, pp. 2759-2769